These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 28821057)
1. A cell-penetrating peptide mediated chitosan nanocarriers for improving intestinal insulin delivery. Li L; Yang L; Li M; Zhang L Carbohydr Polym; 2017 Oct; 174():182-189. PubMed ID: 28821057 [TBL] [Abstract][Full Text] [Related]
2. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation. Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840 [TBL] [Abstract][Full Text] [Related]
3. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
4. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid. Chen Z; Han S; Yang X; Xu L; Qi H; Hao G; Cao J; Liang Y; Ma Q; Zhang G; Sun Y Int J Nanomedicine; 2020; 15():4877-4898. PubMed ID: 32753869 [TBL] [Abstract][Full Text] [Related]
5. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809 [TBL] [Abstract][Full Text] [Related]
6. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin. Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Tong Z; Kong X; Yao J Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):278-286. PubMed ID: 27770892 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study. Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176 [TBL] [Abstract][Full Text] [Related]
8. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides. Guo F; Ouyang T; Peng T; Zhang X; Xie B; Yang X; Liang D; Zhong H Biomater Sci; 2019 Mar; 7(4):1493-1506. PubMed ID: 30672923 [TBL] [Abstract][Full Text] [Related]
9. Amphiphilic Lipopeptide-Mediated Transport of Insulin and Cell Membrane Penetration Mechanism. Zhang Y; Li L; Han M; Hu J; Zhang L Molecules; 2015 Dec; 20(12):21569-83. PubMed ID: 26633348 [TBL] [Abstract][Full Text] [Related]
10. A novel ligand conjugated nanoparticles for oral insulin delivery. Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690 [TBL] [Abstract][Full Text] [Related]
11. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation. Liu L; Zhou C; Xia X; Liu Y Int J Nanomedicine; 2016; 11():761-9. PubMed ID: 26966360 [TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
13. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery. Wang J; Kong M; Zhou Z; Yan D; Yu X; Cheng X; Feng C; Liu Y; Chen X Carbohydr Polym; 2017 Feb; 157():596-602. PubMed ID: 27987967 [TBL] [Abstract][Full Text] [Related]
15. Oral insulin delivery by carboxymethyl-β-cyclodextrin-grafted chitosan nanoparticles for improving diabetic treatment. Song M; Wang H; Chen K; Zhang S; Yu L; Elshazly EH; Ke L; Gong R Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S774-S782. PubMed ID: 30280608 [TBL] [Abstract][Full Text] [Related]
16. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin. Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441 [TBL] [Abstract][Full Text] [Related]
17. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663 [TBL] [Abstract][Full Text] [Related]
18. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration. Urimi D; Agrawal AK; Kushwah V; Jain S AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757 [TBL] [Abstract][Full Text] [Related]
19. pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery. Zhang YW; Tu LL; Tang Z; Wang Q; Zheng GL; Yin LN Pharm Dev Technol; 2021 Nov; 26(9):943-952. PubMed ID: 34372745 [TBL] [Abstract][Full Text] [Related]
20. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec). Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]